Lid Nystagmus as a Sign of Intrinsic Midbrain Disease
J Neuro-Ophthalmol 15:236-240, Brodsky,M.C.&Boop,F.A., 1995
Myasthenic Symptoms in Patients with Mitochondrial Myopathies
Muscle & Nerve 18:1338-1340995., Forestier,N.L.,et al, 1995
Congenital Myasthenic Syndromes
In:Neurologic Clinics, 12:401-4371994., Engel,A.G., 1994
Clinicopath Conf
Small Cell CA (of lung) with Lambert-Eaton Myasthenic Syndr, Case 32-1994, NEJM 331:528-5354., , 1994
Reversal of Subacute Paraneoplastic Cerebellar Syndrome with Intravenous Immunoglobulin
Neurol 44:1184-1185, Counsell,C.E.,et al, 1994
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Ocular Myasthenia Gravis
J Natl Med Assoc 85:681-684, March,G.A.&Johnson,J.N., 1993
Acetylcholine Receptor Antibodies in Juvenile Myasthenia Gravis
Neurol 43:977-982, Andrews,P.I.,et al, 1993
Midbrain Myasthenia:Fatigable Ptosis, 'Lid Twitch'Sign, and Ophthalmoparesis From a Dorsal Midbrain Glioma
Neurol 42 917-919, Ragge,N.K.&Hoyt,W.F., 1992
Clinical and Electrophysiologic Improvement in Lambert-Eaton Syndrome with Intravenous Immunoglobulin Therapy
Neurol 42:1422-1423, Bird,S.J., 1992
Trends in the Association of Lambert-Eaton Myasthenic Syndrome with Carcinoma
Neurol 42:848-850, Gutmann,L.,et al, 1992
Paraneoplastic Cerebellar Degener III, Cerebellar Degener, Cancer & Lambert-Eaton Myasthenic Synd
Neurol 42:1944-1950, Clouston,P.D.,et al, 1992
Aggravation of Myasthenia Gravis by Erythromycin
J Pediatr 119:155-156, Absher,J.R.&Bale,J.F., 1991
Myasthenia Gravis Unmasked by Cocaine Abuse
NEJM 325:892, Berciano,J.,et al, 1991
Neurological Paraneoplastic Syndromes in Patients with Small Cell Lung Cancer, A Prospective Survey of 150 Pts
JNNP 54:764-767, Elrington,G.M.,et al, 1991
Calcium Channel Autoantibodies in the Lambert-Eaton Myashenic Syndrome
Ann Neurol 29:307-314, Leys,K.,et al, 1991
Aggravation of Myasthenia Gravis by Erythromycin
Ann Neurol 28:577-579, May,E.F.&Calvert,P.C., 1990
Edrophonium Responsiveness not Necessarily Diagnostic of Myasthenia Gravis
Muscle & Nerve 13:187-191990., Oh,S.J.&Cho,H.K., 1990
Response of the Lambert-Eaton Myasthenic Syndrome to Treatment of Associated Small-Cell Lung Carcinoma
Neurol 40:1552-1556, Chalk,C.H.,et al, 1990
Neuromuscular Blockade
Lancet 335:382-384, , 1990
Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990
The Remote Effects of Cancer on the Nervous System
in Neurol Manif of Systemic Dis, W. B. Saunders, Co, Phila, Neurologic Clinics 7:579-603, Dropcho,E.J., 1989
Ocular Pseudomyasthenia or Ocular Myasthenia'Plus':A Warning to Clinicians
Neurol 39:1150-1154, Moorthy,G.,et al, 1989
3, 4-Diaminopyridine in the Treatment of Lambert-Eaton Myasthenic Syndrome
NEJM 321:1567-1571, 1607-16081989., McEvoy,K.M.,et al, 1989
Specificity of Calcium Channel Autoantibodies in Lambert-Eaton Myasthenic Syndrome
Lancet 2:640-643, Sher,E.,et al, 1989
Autoantibody Activity in Lambert-Eaton Myasthenic Syndrome
Editorial, Lancet 1:9201988., , 1988
The Lambert-Eaton Myasthenic Syndrome, A Review of 50 Cases
Brain 111, 577-5961988., O'Neill,J.H.,et al, 1988
Parkinson's Disease & Myasthenia Gravis:Adverse Effect of Trihexyphenidyl on Neuromuscular Transmission
Neurol 37:832-833, Ueno,S.,et al, 1987
The Eaton-Lambert (Myasthenic) Syndrome in Association with Systemic Lupus Erythematosus
Arch Neurol 43:1186-1187, Hughes,R.L.&Katirji,M.B., 1986
Worsening of Myasthenia Gravis with Timolol Maleate Eyedrops
Ann Neurol 17:211-212, Verkijk,A., 1985
Plasma Exchange & Immunosuppressive Drug Treatment in the Lambert-Eaton Myasthenic Syndrome
Neurol 34:480-485, Newsom-Davis,J.,et al, 1984
The Neurotoxicity of Antibacterial Agents
Ann Int Med 101:92-104, Snavely,S.R.,et al, 1984
Myasthenia Gravis & Myasthenic Syndromes
Ann Neurol 16:519-534, Engel,A.G., 1984
Treatment of Lambert-Eaton Syndrome:3, 4-Diaminopyridine & Pyridostigmine
Neurol 34:1324-1330, Lundh,H.,et al, 1984
Beta-Adrenoreceptor Antagonists & Diplopia
Lancet 2:826-827, Weber,J.C.P., 1982
Plasmapheresis & Immunosuppressive Drug Therapy in the Eaton-Lambert Syndrome
Ann Neurol 11:570-575, Da,P.C.,et al, 1982
Treatment with Oral 4-aminopyridine in Disorders of Neuromuscular Transmission
Neurol 31:265-271, Murray,N.M.F.,et al, 1981
Eaton-Lambert Myasthenic Syndrome:Long-term Treatment of Three Patients with Prednisone
Ann Neurol 10:448-453, Streib,E.W.,et al, 1981
Procainamide-Induced Myasthenia-like Weakness in a Patient with Peripheral Neuropathy
Arch Neurol 38:378-379, Niakan,E.,et al, 1981
Eaton-Lambert Syndrome & Malignant Thymoma
Neurol 30:634-638, Lauritzen,M.,et al, 1980
Disorders of Neuromuscular Transmission Caused by Drugs
NEJM 301:409-413, Argov,Z.,et al, 1979
Content of Acetylch Receptor & Antib Bound to Receptor in Myasth Gravis, Experi Autoimm Myasth Gravis, & Syndrome
Neurol 28:130, Lindstrom,J.M., 1978
Familial Neuromuscular Disease with Type 1 Fiber Hypoplasia, Tubular Aggregates, Cardiomyopathy, & Myasthenic Features
Neurol 28:1135-1140, Dobkin,B.H.,et al, 1978
Clinical Syndromes of Myasthenia in Infancy & Childhood
Arch Neurol 35:97, Fenichel,G.M., 1978
4-Aminopyridine-A New Drug Tested in the Treatment of Eaton-Lambert Syndrome
JNNP 40:1109, Lundh,H.,et al, 1977
Adverse Effects of Magnesium Salt Cathartics in a Patient with the Myasthenic Syndrome (Lambert-Eaton Syndrome)
Ann Neurol 2:175, Streib,E.W., 1977
Myasthenia Gravis Assoc. with Wasp Sting
JAMA 235:2120, Brumlik,J., 1976
Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975
The Eaton-Lambert Syndrome in Ocular Myasthenia Gravis
Arch Neurol 31:183-186, Oh,S.J., 1974
Electrodiagnosis Studies in Neuromuscular Disease
NEJM 285:1244, Samaha,F., 1971